Neumora and RayzeBio Aim for Over $200M Each in IPOs
TL;DR Summary
Biotech companies Neumora and RayzeBio are planning to raise around $227 million and $206 million, respectively, in their upcoming IPOs on Nasdaq. Neumora, a neuroscience startup, aims to offer 14.7 million shares under the ticker "NMRA," while RayzeBio, a radiopharmaceuticals developer, plans to list as "RYZB" and offer 13.2 million shares.
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
0 min
vs 1 min read
Condensed
56%
117 → 51 words
Want the full story? Read the original article
Read on Endpoints News